HIV+Hep in the News

;

‘We’ve watched her live in pain.’ Why some Sacramento families can’t afford needed medication

by | Jul 31, 2024

The problem is that insurance companies are not accepting copay assistance toward a patient’s deductible due to a practice known as a copay accumulator, according to Carl Schmid, executive director of the HIV + Hepatitis Policy Institute. “So insurers are taking the money, but they’re not applying it to the person’s out-of-pocket costs and their deductible,” Schmid said. “And then the insurers make the patient pay for the costs.”

read more

Federal HIV program set to wind down

by | Jul 23, 2024

One reason for the program’s low uptake, those advocates said, is that it only covered the costly PrEP medication but not the doctor visits or blood work necessary for a prescription. It also did not include funding for outreach or education about the drug. “It just proves that it’s not just the price of the drug, it’s all the other services that go with PrEP,” Carl Schmid, president of the HIV+Hepatitis Policy Institute, said. “You need a doctor to provide the drug, you need the labs — that was the failure.”

read more

Updated CMS guidance on long-acting PrEP needed, advocates say

by | Jul 18, 2024

“If Trump is re-elected President, we would hope he will support increases in order to fund the Ending the HIV Epidemic initiative (program) he launched,” Carl Schmid, executive director of the HIV+Hepatitis Policy Institute, said in a statement to Inside Health Policy. “The Senate will most likely proceed in a bipartisan fashion, which bodes well for us. But we realize the situation we are in and will continue to educate members on both sides of the aisle on the importance of funding domestic HIV programs.”

read more

Search

Pin It on Pinterest

Share This